johnthomas75's profile picture. ᴘʜʏꜱɪᴄɪᴀɴ, ᴀʀᴛɪꜱᴛ, ᴇxᴘʟᴏʀᴇʀ, ᴀᴄᴛɪᴠɪꜱᴛ, ᴀɴᴅ ʀᴇꜱᴇᴀʀᴄʜᴇʀ
#ʙɪᴏꜱᴛᴀᴛꜱ #ᴘᴇᴅᴏɴᴄ #ʀᴀᴅᴏɴᴄ #ꜱᴜʀᴠᴏɴᴄ #ʀᴀᴅᴏɴᴄ_ᴀɪ
http://publons.com/researcher/513…

𝗝𝗼𝗵𝗻 𝗟𝘂𝗰𝗮𝘀

@johnthomas75

ᴘʜʏꜱɪᴄɪᴀɴ, ᴀʀᴛɪꜱᴛ, ᴇxᴘʟᴏʀᴇʀ, ᴀᴄᴛɪᴠɪꜱᴛ, ᴀɴᴅ ʀᴇꜱᴇᴀʀᴄʜᴇʀ #ʙɪᴏꜱᴛᴀᴛꜱ #ᴘᴇᴅᴏɴᴄ #ʀᴀᴅᴏɴᴄ #ꜱᴜʀᴠᴏɴᴄ #ʀᴀᴅᴏɴᴄ_ᴀɪ http://publons.com/researcher/513…

Pinned

A Phase IV Trial of Proton Therapy in Children: The First Report from the SJPROTON1 Study John T. Lucas Jr, ..., Melissa Hudson, Shengjie Wu, Yimei Li, Matthew J. Krasin, Thomas E. Merchant doi: doi.org/10.1101/2022.1… medrxiv.org/content/10.110…


𝗝𝗼𝗵𝗻 𝗟𝘂𝗰𝗮𝘀 reposted

This slide gives us #PHODocs in #ClinicalInformatics palpitations -- the good kind. I'm glad to have the opportunity to contribute to building the CCDI #Data #Ecosystem! #Data4ChildhoodCancer @NCIKerlavage

WayneLiangMD's tweet image. This slide gives us #PHODocs in #ClinicalInformatics palpitations -- the good kind. 

I'm glad to have the opportunity to contribute to building the CCDI #Data #Ecosystem! #Data4ChildhoodCancer

@NCIKerlavage

𝗝𝗼𝗵𝗻 𝗟𝘂𝗰𝗮𝘀 reposted

Excited to have the opportunity to present our work and be part of this fantastic panel. #Data4ChildhoodCancer #CCDI

#CCDI #Data4ChildhoodCancer Richard Aplenc @ChildrensPhila & @tpmiller12 @ATLPedsHemOnc: Via manual chart review, we miss 66% Adverse Events on #clinicaltrials. 25% submitted AEs are incorrect. #ExtractEHR is a R-based program that queries #EHR to extract clinical research data

WayneLiangMD's tweet image. #CCDI #Data4ChildhoodCancer
Richard Aplenc @ChildrensPhila & @tpmiller12 @ATLPedsHemOnc:
Via manual chart review, we miss 66% Adverse Events on #clinicaltrials. 25% submitted AEs are incorrect.
#ExtractEHR is a R-based program that queries #EHR to extract clinical research data


Please enroll your patients!

Currently recruiting: #NCTN #NCORP Study ACCL2031 led by @COGorg to see if Memantine protects the brain during radiation therapy treatment for brain tumor in children. Learn more: ncorp.cancer.gov/find-a-study/f…

COGorg's tweet image. Currently recruiting: #NCTN #NCORP Study ACCL2031 led by @COGorg to see if Memantine protects the brain during radiation therapy treatment for brain tumor in children. Learn more: ncorp.cancer.gov/find-a-study/f…


𝗝𝗼𝗵𝗻 𝗟𝘂𝗰𝗮𝘀 reposted

I used DALL·E 2's inpainting feature to make a version of Eames Powers of Ten, leaving the prompts in to explain each of the 57 steps. #DALLE @OpenAI #AI


𝗝𝗼𝗵𝗻 𝗟𝘂𝗰𝗮𝘀 reposted

🧒 Analysis from the PPB/DICER1 Registry highlights outcomes in the largest-ever cohort of children with advanced pleuropulmonary blastoma, treated at 204 centers in 47 countries. 👉 fal.cn/3sHDn @ppbdicer1 #pedcsm #LCSM #EarliestAndMostCurableForm #EveryJourneyMatters

JCO_ASCO's tweet image. 🧒 Analysis from the PPB/DICER1 Registry highlights outcomes in the largest-ever cohort of children with advanced pleuropulmonary blastoma, treated at 204 centers in 47 countries. 👉 fal.cn/3sHDn @ppbdicer1 #pedcsm #LCSM #EarliestAndMostCurableForm #EveryJourneyMatters

𝗝𝗼𝗵𝗻 𝗟𝘂𝗰𝗮𝘀 reposted

We're proud to continue our partnership with @StJude as the benefiting charity partner of #MemphoFest. Join music fans for three days of music, including @theblackkeys, @Wilco, @JasonIsbell, and many more. Even better, you’ll be helping the lifesaving mission of #StJude.

MemphoFest's tweet image. We're proud to continue our partnership with @StJude as the benefiting charity partner of #MemphoFest. Join music fans for three days of music, including @theblackkeys, @Wilco, @JasonIsbell, and many more. Even better, you’ll be helping the lifesaving mission of #StJude.

The collapse of the pay wall?!! White House requires immediate public access to all U.S.-funded research papers by 2025 science.org/content/articl… #oncology


𝗝𝗼𝗵𝗻 𝗟𝘂𝗰𝗮𝘀 reposted

Proxy Variable xkcd.com/2652

xkcd's tweet image. Proxy Variable xkcd.com/2652

𝗝𝗼𝗵𝗻 𝗟𝘂𝗰𝗮𝘀 reposted

We're excited to announce Quarto, a new open-source scientific and technical publishing system. Quarto is the next generation of R Markdown and takes what we've learned from the last 10 years and weave it into a more complete, cohesive whole. Read more: rstudio.com/blog/announcin…


Loading...

Something went wrong.


Something went wrong.